ROLE OF PERCUTANEOUS TIBIAL NERVE STIMULATION (PTNS) IN THE TREATMENT OF NEUROGENIC OVERACTIVE BLADDER SYNDROME Perugia G., Corongiu E., Borgoni.

Slides:

Advertisements

Similar presentations

DONNA T. GALLAGHER MS, FNP-C, CUNP

Advertisements

Jonah Murdock, MD PhD Mid Atlantic Urology Associates July 2011.

Urinary Incontinence Kieron Durkan GPST 1.

Understanding Urodynamics Kim Duggan, RNC. Understanding Urodynamics Urodynamics is a study that assess how the bladder and urethra are performing their.

OnabotulinumtoxinA for Urinary Incontinence from Neurogenic Detrusor Overactivity.

Janice Reid Continence Services Manager Western Health & Social Care Trust 29/01/2014 LSA Midwifery Conference Mossley Mill.

Urodynamic study 新光吳火獅紀念醫院婦產科潘恆新醫師. Urinary incontinence Urinary incontinence is a condition in which involuntary loss of urine is a social or hygienic.

Urodynamic Findings and Diagnosis in Aging People

Urinary incontinence in women October Changing clinical practice NICE guidelines are based on the best available evidence The Department of Health.

Physiotherapy approaches for urgency and urge incontinence Liz Childs Pelvic Health Physiotherapist.

Lower Urinary Tract Symptoms in Men

2008. Causes of symptoms  Hyperplasia of epithelial and stromal components of prostate  Progressive obstruction of urinary outflow  Increased activity.

Urinary Incontinence in women. Urinary incontinence Stress – involuntary leakage of urine on effort, sneezing or coughing Urgency – involuntary leakage.

LUTS Shawket Alkhayal Consultant Urological Surgeon Benenden Hospital Tunbridge Wells Nuffield Hospital.

Study day clinical cases nd Seminar Clinical cases in urodynamics. One morning with Paul Abrams Presented by: Dr. Jose Emilio Batista Centro Médico.

Study day clinical cases nd Seminar Clinical cases in urodynamics. One morning with Paul Abrams presented by: Dr. Jose Emilio Batista Centro Médico.

 Stephen T Jeffery University of Cape Town, South Africa Urogynaecology and laparoscopy clinic

Keeping the right patients away from hospital

Sharon English Urologist Christchurch

Sacral Neuromodulation in 52 Patients Suffering From Bladder Disorders and/or Pelvic Pain G. Babbolin G. Colini Baldeschi.

Back to Basics A&P NZCA September 16, URETHRAL RESISTANCE Smooth muscle Striated muscle External urethral sphincter Pelvic floor muscles Mucosal.

Overactive Bladder Jerry G. Blaivas, MD Clinical Professor of Urology Weil Cornell Medical College New York Presbyterian Hospital Adjunct Professor of.

Over active bladder drug treatment Mark Weatherall University of Otago Wellington.

Study day clinical cases nd Seminar Clinical cases in urodynamics. One morning with Paul Abrams Presented by: Dr. Jose Emilio Batista Urodynamics.

Introduction 1% to 40% incidence, depending on how incontinence is defined Often resolves within the first postoperative year 95% of men with post-prostatectomy.

Prevalence, Evaluation and Management of Overactive Bladder in Primary Care SUNY-DOWNSTATE MEDICAL CENTER BROOKLYN, New York NADIA KHAN, MD* Miriam Vincent,

Interna tional Neurourology Journal 2016;20:81-85 Intravesical OnabotulinumtoxinA Injection for Overactive Orthotopic Ileal Neobladder: Feasibility and.

Controlling Urine Leakage What You Need To Know David Spellberg MD,FACS Controlling Urine Leakage What You Need To Know David Spellberg MD,FACS.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( org/licenses/by-nc/3.0/)

INTERSTIM ® THERAPY for Urinary Control. What are Bladder Control Problems? Broad range of symptoms –May leak small or large amount of urine –May leak.

International Neurourology Journal 2015;19: Practical Aspects of Botulinum Toxin-A Treatment in Patients With Overactive Bladder Syndrome Chun-Hou.

COMMUNITY CONTINENCE ADVISORY SERVICE SHIRLEY BUDD CONTINENCE CLINICAL LEAD Continence Assessments 1.

Women’s Health Kate Brocklehurst 17/07/2013. What we will cover What we’ve got and how it works What goes wrong? Terminology Women’s health assessment.

Date of download: 6/29/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Interpretation of multichannel urodynamic evaluation: cystometrogram.

URINARY INCONTINENCE Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara.

โดย เภสัชกรณัฐวุฒิ จรีบุญ สมโภช. OAB affects 33 million people in the United States (17% of American adults) more common in women and in older people.

Interna tional Neurourology Journal 2010;14:26-33 Predictors of Postoperative Voiding Dysfunction following Transobsturator Sling Procedures in Patients.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( org/licenses/by-nc/3.0/)

The Prevalence and Therapeutic Effect of Constipation in Pediatric Overactive Bladder Ji Hyun Kim, Ji Hyun Lee, A Young Jung 1, Jung Won Lee Departments.

GENUINE STRESS INCONTINENCE PRESENTER:DR SWETA SINGH MODERATOR:DR DEEPA CHUDAL.

CLINICAL SIGNIFICANCE

International Neurourology Journal 2013;17:

International Neurourology Journal 2015;19:

Urology & Nephrology Center, Mansoura, EGYPT

METHODS AND MATERIALS: SCIENTIFIC/CLINICAL SIGNIFICANCE:

Urinary Symptoms in the Female

Urinary Nerve Growth Factor Levels are Elevated in Patients with Detrusor Overactivity and Decreased in Responders to Detrusor Botulinum Toxin-A Injection

International Neurourology Journal 2012;16:

Sacral Neuromodulation in Patients With a Cardiac Pacemaker

International Neurourology Journal 2015;19:

Success of a repeated tined lead trial in a refractory OAB population

#96 Roles Of Urodynamics In the Assessment of Post Radical

1Bristol Urological Institute 2Astellas Pharma Europe B.V.

Predictors of Longterm Sacral Nerve Stimulation Failures

497 MIRABEGRON IS A SAFE AND EFFECTIVE TREATMENT FOR PARKINSON’S DISEASE PATIENTS WITH STORAGE SYMPTOMS REFRACTORY TO ANTIMUSCARINICS Soto Troya I1 , Park.

Management of Male OAB; Current Status in Japan

Jose D Roman M.D. Braemar Hospital, Hamilton, NEW ZEALAND

OB,GYN / Fellowship of Pelvic Floor

Bladder dysfunction in ALD and AMN

Bladder Dysfunction Associated With Parkinson’s Disease

Filling Cystometry Carlos D’Ancona, Mario João Gomes, Peter F.W.M. Rosier.

Volume 51, Issue 2, Pages (February 2007)

Nat. Rev. Urol. doi: /nrurol

Initial Office Evaluation

Botulinum Toxin Type A Injections for Treating Neurogenic Detrusor Overactivity Combined With Low-Compliance Bladder in Patients With Spinal Cord Lesions

Nat. Rev. Urol. doi: /nrurol

Economic and Social Impact of OAB

Comparison of protocols for tibial nerve electrical stimulation for the treatment of overactive bladder: clinical trial randomized blind Pierre ML, Toscano.

Initial Office Evaluation for OAB

ICS TEACHING MODULE Urodynamics in children Part 2

Presentation transcript:

ROLE OF PERCUTANEOUS TIBIAL NERVE STIMULATION (PTNS) IN THE TREATMENT OF NEUROGENIC OVERACTIVE BLADDER SYNDROME Perugia G., Corongiu E., Borgoni G., Polese M., Prontera P.P., Olivieri V., Liberti M. Department of Gynaecological-Obstetric and Urologycal Sciences, ”Sapienza”, University of Rome, Italy.

Overactive bladder syndrome (OAB) is characterized by a series of urinary symptoms such as incontinence, urgency, frequency, nocturia and it is differentiated in OAB due to an involuntary urodynamic detrusor contraction, and Neurogenic Detrusor Overactivity (NDO). Many neurologic pathologies can be responsible of NDO. The study is proposed to evaluate the results on symptoms and urodynamic findings of PTNS in patients with NDO.

12 pts.,9 males and 3 females,age ranged from 25 and 76 years, with clinical and urodynamic diagnosis of NDO, underwent electrical tibial nerve stimulations , unilaterally, from the medial malleolus and posteriorly to the edge of the tibia, twice a week for a total of 6 weeks. Urodynamic parameters, OverActive Bladder Symptoms Score (OABSS) and voiding diary were evaluated in all pts. before treatment, after 6 elettrical stimulations and at the end of treatment.

RESULTS PTNS was found to be effective on OAB symptoms in all pts. Mean 1st involuntary detrusor contraction ( IDC ) and mean maximum cistometric capacity ( MCC ) were significantly improved on standard cystometry. 8 pts. (66,6%) showed a complete disappearance of IDC and the other 4pts. (33,3%) showed an increased filling volume to IDC. No complications have been reported, and pts. compliance to treatment was very high.

RESULTS

CONCLUSIONS PTNS is an effective and safe option to treat pts. with symptoms from NDO. Further studies are needed to assess the role of this technique, and to establish the length of treatment in order to maintain the results obtained.